FindTrial
Sign In

Acute benefits of Wasabi tablets on cognition and neural activity

Acute benefits of Wasabi tablets on cognition and neural activity - Acute benefits of Wasabi tablets on cognition and neural activity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036461
Enrollment
40
Registered
2019-04-10
Start date
2019-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Young Healthy adults

Interventions

Intake a Wasabi tablet once Intake a placebo table once

Sponsors

Tohoku Univerisity
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Right handed Japanese native adults

Exclusion criteria

Exclusion criteria: Who have a medical history of mental disorder or neurological disorder take medical drug which may affect the brain and cognition have a visual disability Allergy for food is participating in other intervention studies

Design outcomes

Primary

MeasureTime frame
Brain activity during cognitive tasks—

Secondary

MeasureTime frame
STAI:State Trait Anxiety Inventory WHO-5:WHO Five well-being index GHQ12:General Health Questionnaire 12 CES-D:center for epidemiologic studies depression scale Sleep scale brief-type self-administered diet history questionnaire daily activities Ten Item Personality Inventory Effortful control scale Profile of Mood States2 TDMS-ST:Two dimensional Mood Scale-Short Term VAS for tastiness of Wasabi tablet—

Countries

Japan

Contacts

Public ContactRui Nouchi

Tohoku Univeristy IDAC

rui@tohoku.ac.jp022-717-8952

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026